FFA
NVO

Farther Finance Advisors’s Novo Nordisk NVO Stock Holding History

Farther Finance Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$50.9K – 5855
2025
Q4 		$50.9K Buy
+1,000
New +$51.1K ﹤0.01% 2805

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Farther Finance Advisors's NVO Position: Q2 2026 in Review

Farther Finance Advisors reduced its Novo Nordisk (NVO) stake by 4.6% in Q2 2026, selling an estimated $173K and leaving 83,020 shares worth $3.98M. The position accounts for 0.03% of the portfolio, ranked #472.

Farther Finance Advisors first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.12M in Q2 2025. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Farther Finance Advisors held 83,020 shares of Novo Nordisk worth $3.98M as of Q2 2026.
  • Farther Finance Advisors sold 4,035 Novo Nordisk shares in Q2 2026, an estimated $173K.
  • Novo Nordisk made up 0.03% of Farther Finance Advisors's portfolio in Q2 2026, its #472 holding.
  • Farther Finance Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Novo Nordisk position peaked at $7.12M in Q2 2025.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.